Srikripa Devarakonda
Stock Analyst at Truist Financial
Total Price Targets
15
Stocks Covered
11
Sectors
Healthcare
Most Recent
Apr 14, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Srikripa Devarakonda
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc. | $121.00 | $98.16 | +23.3% | 3 | Apr 14, 2026 |
| ARVN | Arvinas, Inc. | $10.00 | $10.55 | -5.2% | 2 | Mar 18, 2026 |
| MBX | MBX Biosciences, Inc. Common Stock | $50.00 | $30.09 | +66.2% | 1 | Mar 9, 2026 |
| SRRK | Scholar Rock Holding Corporation | $55.00 | $46.75 | +17.6% | 1 | Mar 3, 2026 |
| CYTK | Cytokinetics, Incorporated | $92.00 | $64.40 | +42.9% | 2 | Feb 3, 2026 |
| INCY | Incyte Corporation | $103.00 | $96.41 | +6.8% | 1 | Dec 24, 2025 |
| KYMR | Kymera Therapeutics, Inc. | $116.00 | $81.54 | +42.3% | 1 | Dec 9, 2025 |
| BMY | Bristol-Myers Squibb Company | $65.00 | $58.22 | +11.6% | 1 | Dec 3, 2025 |
| LLY | Eli Lilly and Company | $1182.00 | $961.67 | +22.9% | 1 | Nov 19, 2025 |
| EWTX | Edgewise Therapeutics, Inc. | $50.00 | $30.63 | +63.2% | 1 | Dec 5, 2024 |
| KROS | Keros Therapeutics, Inc. | $100.00 | $11.48 | +771.1% | 1 | Nov 5, 2024 |
Recent Activity
- Apr 14, 2026— Set$121.00price target onPTGX(Protagonist Therapeutics, Inc.)
- Mar 18, 2026— Set$10.00price target onARVN(Arvinas, Inc.)
- Mar 9, 2026— Set$50.00price target onMBX(MBX Biosciences, Inc. Common Stock)
- Mar 3, 2026— Set$55.00price target onSRRK(Scholar Rock Holding Corporation)
- Feb 3, 2026— Set$92.00price target onCYTK(Cytokinetics, Incorporated)
- Dec 24, 2025— Set$103.00price target onINCY(Incyte Corporation)
- Dec 22, 2025— Set$84.00price target onCYTK(Cytokinetics, Incorporated)
- Dec 9, 2025— Set$116.00price target onKYMR(Kymera Therapeutics, Inc.)
- Dec 3, 2025— Set$65.00price target onBMY(Bristol-Myers Squibb Company)
- Nov 19, 2025— Set$1182.00price target onLLY(Eli Lilly and Company)
- Oct 28, 2025— Set$88.00price target onPTGX(Protagonist Therapeutics, Inc.)
- May 5, 2025— Set$11.00price target onARVN(Arvinas, Inc.)
- Dec 5, 2024— Set$50.00price target onEWTX(Edgewise Therapeutics, Inc.)
- Nov 22, 2024— Set$60.00price target onPTGX(Protagonist Therapeutics, Inc.)
- Nov 5, 2024— Set$100.00price target onKROS(Keros Therapeutics, Inc.)
Frequently Asked Questions
Who is Srikripa Devarakonda?
Srikripa Devarakonda is a stock analyst at Truist Financial covering 11 stocks primarily in Healthcare. They have issued 15 price targets since Nov 5, 2024.
What stocks does Srikripa Devarakonda cover?
Srikripa Devarakonda currently covers 11 stocks, including PTGX, ARVN, CYTK, MBX, SRRK.
What is Srikripa Devarakonda's latest price target?
Srikripa Devarakonda's most recent price target was $121.00 on PTGX (Protagonist Therapeutics, Inc.), set on Apr 14, 2026.
What is Srikripa Devarakonda's highest price target?
Srikripa Devarakonda's highest issued price target is $1182.00 on LLY, set on Nov 19, 2025.
More Analysts at Truist Financial
Coverage based on publicly published price targets. Not investment advice.